Cargando…

Innovation to Advance Cancer Control Equitably

Detalles Bibliográficos
Autores principales: Kutluk, Tezer, Johnson, Sonali, Tittenbrun, Zuzanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812454/
https://www.ncbi.nlm.nih.gov/pubmed/36252161
http://dx.doi.org/10.1200/GO.22.00301
_version_ 1784863730088017920
author Kutluk, Tezer
Johnson, Sonali
Tittenbrun, Zuzanna
author_facet Kutluk, Tezer
Johnson, Sonali
Tittenbrun, Zuzanna
author_sort Kutluk, Tezer
collection PubMed
description
format Online
Article
Text
id pubmed-9812454
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-98124542023-01-05 Innovation to Advance Cancer Control Equitably Kutluk, Tezer Johnson, Sonali Tittenbrun, Zuzanna JCO Glob Oncol OVERVIEWS Wolters Kluwer Health 2022-10-17 /pmc/articles/PMC9812454/ /pubmed/36252161 http://dx.doi.org/10.1200/GO.22.00301 Text en © 2022 by American Society of Clinical Oncology https://creativecommons.org/licenses/by/4.0/Licensed under the Creative Commons Attribution 4.0 License: https://creativecommons.org/licenses/by/4.0/
spellingShingle OVERVIEWS
Kutluk, Tezer
Johnson, Sonali
Tittenbrun, Zuzanna
Innovation to Advance Cancer Control Equitably
title Innovation to Advance Cancer Control Equitably
title_full Innovation to Advance Cancer Control Equitably
title_fullStr Innovation to Advance Cancer Control Equitably
title_full_unstemmed Innovation to Advance Cancer Control Equitably
title_short Innovation to Advance Cancer Control Equitably
title_sort innovation to advance cancer control equitably
topic OVERVIEWS
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812454/
https://www.ncbi.nlm.nih.gov/pubmed/36252161
http://dx.doi.org/10.1200/GO.22.00301
work_keys_str_mv AT kutluktezer innovationtoadvancecancercontrolequitably
AT johnsonsonali innovationtoadvancecancercontrolequitably
AT tittenbrunzuzanna innovationtoadvancecancercontrolequitably